2. Academic Validation
  3. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response

Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response

  • Nat Commun. 2025 Mar 4;16(1):2175. doi: 10.1038/s41467-025-57465-7.
Junquan Song # 1 2,  Rongyuan Wei # 1 2,  Chenchen Liu # 1 2,  Zhenxiong Zhao 1 2,  Xuanjun Liu 1 2,  Yanong Wang 3 4,  Fenglin Liu 5 6,  Xiaowen Liu 7 8
Affiliations

Affiliations

  • 1 Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • 2 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China.
  • 3 Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. drwangyn@126.com.
  • 4 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China. drwangyn@126.com.
  • 5 Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. fenglinliu@hotmail.com.
  • 6 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China. fenglinliu@hotmail.com.
  • 7 Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. liuxw1129@hotmail.com.
  • 8 Department of Oncology, Shanghai Medical College of Fudan University, Shanghai, China. liuxw1129@hotmail.com.
  • # Contributed equally.
PMID: 40038297 DOI: 10.1038/s41467-025-57465-7
Abstract

Cancer-associated fibroblasts (CAF) play a crucial role in tumor progression and immune regulation. However, the functional heterogeneity of CAFs remains unclear. Here, we identify antigen-presenting CAFs (apCAF), characterized by high MHC II expression, in gastric Cancer (GC) tumors and find that apCAFs are preferentially located near tertiary lymphoid structures. Both in vivo and in vitro experiments demonstrate that apCAFs promote T cell activation and enhances its cytotoxic and proliferative capacities, thereby strengthening T cell-mediated anti-tumor immunity. Additionally, apCAFs facilitate the polarization of macrophages toward a pro-inflammatory phenotype. These polarized macrophages, in turn, promote the formation of apCAFs, creating a positive feedback loop that amplifies anti-tumor immune responses. Notably, baseline tumors in immunotherapy responders across various Cancer types exhibit higher levels of apCAFs infiltration. This study advances the understanding of CAFs heterogeneity in GC and highlights apCAFs as a potential biomarker for predicting immunotherapy response in pan-cancer.

Figures
Products
Inhibitors & Agonists
Other Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z